Search Results

Part of a family of prescription drugs known as incretin mimetics, Onglyza (saxagliptin) and Kombiglyze XR (saxagliptin and metformin HCl) are used to treat Type 2 diabetes. But new data suggests that taking Onglyza or Kombiglyze XR may increase the risk of pancreatic cancer, thyroid cancer, and heart failure, a fatal condition in which the heart can’t pump enough blood (more...)